<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wei Q</submitter><funding>BLRD VA</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>NIDDK NIH HHS</funding><funding>National Natural Science Foundation of China</funding><funding>US Department of Veterans Affairs</funding><pagination>249-262</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11764320</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(1)</volume><pubmed_abstract>Epigenetic regulations, such as DNA methylation and microRNAs, play an important role in renal fibrosis. Here, we report the regulation of microRNA219a-2 by DNA methylation in fibrotic kidneys, unveiling the crosstalk between these epigenetic mechanisms. Through genome-wide DNA methylation analysis and pyrosequencing, we detected the hypermethylation of microRNA219a-2 in renal fibrosis induced by unilateral ureteral obstruction (UUO) or renal ischemia/reperfusion, which was accompanied by a significant decrease in microRNA-219a-5p expression. Functionally, overexpression of microRNA219a-2 enhanced fibronectin induction during hypoxia or TGF-β1 treatment of cultured renal cells. In mice, inhibition of microRNA-219a-5p suppressed fibronectin accumulation in UUO and ischemic/reperfused kidney</pubmed_abstract><journal>Molecular therapy : the journal of the American Society of Gene Therapy</journal><pubmed_title>Hypermethylation and suppression of microRNA219a-2 activates the ALDH1L2/GSH/PAI-1 pathway for fibronectin degradation in renal fibrosis.</pubmed_title><pmcid>PMC11764320</pmcid><funding_grant_id>R01 DK058831</funding_grant_id><funding_grant_id>R01 DK087843</funding_grant_id><funding_grant_id>I01 BX000319</funding_grant_id><funding_grant_id>R01 DK126763</funding_grant_id><funding_grant_id>IK6 BX005236</funding_grant_id><pubmed_authors>Wei Q</pubmed_authors><pubmed_authors>Hu X</pubmed_authors><pubmed_authors>Dong Z</pubmed_authors><pubmed_authors>Xiao X</pubmed_authors><pubmed_authors>Huo E</pubmed_authors><pubmed_authors>Guo C</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Dong C</pubmed_authors><pubmed_authors>Shi H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hypermethylation and suppression of microRNA219a-2 activates the ALDH1L2/GSH/PAI-1 pathway for fibronectin degradation in renal fibrosis.</name><description>Epigenetic regulations, such as DNA methylation and microRNAs, play an important role in renal fibrosis. Here, we report the regulation of microRNA219a-2 by DNA methylation in fibrotic kidneys, unveiling the crosstalk between these epigenetic mechanisms. Through genome-wide DNA methylation analysis and pyrosequencing, we detected the hypermethylation of microRNA219a-2 in renal fibrosis induced by unilateral ureteral obstruction (UUO) or renal ischemia/reperfusion, which was accompanied by a significant decrease in microRNA-219a-5p expression. Functionally, overexpression of microRNA219a-2 enhanced fibronectin induction during hypoxia or TGF-β1 treatment of cultured renal cells. In mice, inhibition of microRNA-219a-5p suppressed fibronectin accumulation in UUO and ischemic/reperfused kidney</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-06T19:34:14.458Z</modification><creation>2026-06-04T03:10:51.278Z</creation></dates><accession>S-EPMC11764320</accession><cross_references><pubmed>39295147</pubmed><doi>10.1016/j.ymthe.2024.09.020</doi></cross_references></HashMap>